175 related articles for article (PubMed ID: 30060944)
1. Can we move directly from 5-ASA to a biologic agent in ulcerative colitis?
Hindryckx P; Novak G
Best Pract Res Clin Gastroenterol; 2018; 32-33():9-15. PubMed ID: 30060944
[TBL] [Abstract][Full Text] [Related]
2. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Le Berre C; Roda G; Nedeljkovic Protic M; Danese S; Peyrin-Biroulet L
Expert Opin Biol Ther; 2020 Apr; 20(4):363-378. PubMed ID: 31498003
[No Abstract] [Full Text] [Related]
3. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
[TBL] [Abstract][Full Text] [Related]
4. Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?
Lakatos PL; Lakatos L
Pharmacol Res; 2008; 58(3-4):190-5. PubMed ID: 18801439
[TBL] [Abstract][Full Text] [Related]
5. Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts.
Ungaro RC; Limketkai BN; Jensen CB; Allin KH; Agrawal M; Ullman T; Colombel JF; Jess T
Gut; 2019 Jun; 68(6):977-984. PubMed ID: 30420398
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
[TBL] [Abstract][Full Text] [Related]
7. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
8. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis.
Berends SE; Strik AS; Löwenberg M; D'Haens GR; Mathôt RAA
Clin Pharmacokinet; 2019 Jan; 58(1):15-37. PubMed ID: 29752633
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
Shaffer SR; Huang E; Patel S; Rubin DT
Am J Gastroenterol; 2021 Jan; 116(1):125-133. PubMed ID: 32947317
[TBL] [Abstract][Full Text] [Related]
10. The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
Herfarth H
Dig Dis; 2012; 30 Suppl 2():55-9. PubMed ID: 23207933
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminosalicylic acid, a specific drug for ulcerative colitis.
Hauso Ø; Martinsen TC; Waldum H
Scand J Gastroenterol; 2015 Aug; 50(8):933-41. PubMed ID: 25733192
[TBL] [Abstract][Full Text] [Related]
12. Standard treatment of ulcerative colitis.
Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
[TBL] [Abstract][Full Text] [Related]
13. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
14. No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy.
Singh S; Kim J; Zhu W; Dulai PS; Sandborn WJ; Jairath V
Aliment Pharmacol Ther; 2020 Aug; 52(3):481-491. PubMed ID: 32573825
[TBL] [Abstract][Full Text] [Related]
15. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.
Frieri G; Giacomelli R; Pimpo M; Palumbo G; Passacantando A; Pantaleoni G; Caprilli R
Gut; 2000 Sep; 47(3):410-4. PubMed ID: 10940280
[TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis.
Olmstead J
J Am Acad Nurse Pract; 2010 Nov; 22(11):586-92. PubMed ID: 21054632
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Treatment of 5-Aminosalicylic Acid and Treadmill Exercise More Effectively Improves Ulcerative Colitis in Mice.
Jin JJ; Ko IG; Hwang L; Kim SH; Jee YS; Jeon H; Park SB; Jeon JW
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791116
[TBL] [Abstract][Full Text] [Related]
18. Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis.
Yamamoto Y; Masuda S; Nakase H; Matsuura M; Maruyama S; Hisamatsu T; Suzuki Y; Matsubara K
Biol Pharm Bull; 2019 Jan; 42(1):81-86. PubMed ID: 30369547
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.
Kane SV; Bjorkman DJ
Rev Gastroenterol Disord; 2003; 3(4):210-8. PubMed ID: 14668693
[TBL] [Abstract][Full Text] [Related]
20. Will a 5-ASA a day keep the cancer (and dysplasia) away?
Rubin DT; Lashner BA
Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
